R
Richard L. DeVillez
Researcher at University of Texas Health Science Center at San Antonio
Publications - 17
Citations - 1079
Richard L. DeVillez is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Papulonecrotic tuberculid & Finasteride. The author has an hindex of 11, co-authored 17 publications receiving 1010 citations. Previous affiliations of Richard L. DeVillez include American Academy of Dermatology.
Papers
More filters
Journal ArticleDOI
Finasteride in the treatment of men with androgenetic alopecia
Keith D. Kaufman,Elise A. Olsen,David A. Whiting,Ronald C. Savin,Richard L. DeVillez,Wilma F. Bergfeld,Vera H. Price,Dominique Van Neste,Janet L. Roberts,Maria K. Hordinsky,Jerry Shapiro,Bruce Binkowitz,Glenn J. Gormley +12 more
TL;DR: In men with male pattern hair loss, finasteride 1 mg/d slowed the progression of hair loss and increased hair growth in clinical trials over 2 years.
Journal ArticleDOI
Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
Janet L. Roberts,Virginia C. Fiedler,Julianne Imperato-McGinley,David A. Whiting,Elise A. Olsen,Jerome L. Shupack,Dowling B. Stough,Richard L. DeVillez,Robert L. Rietschel,Ronald C. Savin,Wilma F. Bergfeld,James M. Swinehart,Toni Funicella,Maria K. Hordinsky,Nicholas J. Lowe,Irving Katz,Anne W. Lucky,Lynn A. Drake,Vera H. Price,Darryl Weiss,Elizabeth Whitmore,Larry E. Millikan,Sigfrid A. Muller,Christopher Gencheff,Patrick R. Carrington,Bruce Binkowitz,Paul Kotey,Weili He,Karen Bruno,Carol A. Jacobsen,Lisa Terranella,Glenn J. Gormley,Keith D. Kaufman +32 more
TL;DR: Finasteride 1 mg/day is the optimal dose for the treatment of men with male pattern hair loss and was subsequently identified for further clinical development.
Journal ArticleDOI
Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
TL;DR: Combination therapy using drugs with probable different mechanisms of action may provide a synergistic effect in alopecia areata, and the rapidity and extent of hair regrowth were greater with combination therapy than with either drug used as a single agent.
Journal ArticleDOI
Mometasone furoate 0.1%—salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study
John Koo,Cynthia A. Cuffie,Daniel J. Tanner,Renie Bressinck,Roger C. Cornell,Richard L. DeVillez,Libby Edwards,Debra L. Breneman,Daniel Piacquadio,Cynthia Guzzo,Eugene W. Monroe +10 more
TL;DR: Mometasone furoate-salicylic acid ointment provides more effective treatment of moderate-to-severe psoriasis than does mometas one furoates alone and is safe and well tolerated.
Journal ArticleDOI
Oral isotretinoin therapy for familial Muir-Torre syndrome
TL;DR: The rationale for the use of isotretinoin in the Muir-Torre syndrome and the potential for a familial pattern of inheritance and a possible association with the cancer family syndrome are emphasized.